CDC Area of Risk – Risk in Al Bahah, Al Madinah, Asir, Jizan, Makkah, Najran, and Tabuk province. No risk in urban areas of Jeddah, Mecca, Medina, and Ta'if. Chloroquine Resistance – Confirmed.
Recommended Prophylaxis – Atovaquone/ proguanil; doxycycline; or mefloquine.

WHO Malaria risk—predominantly due to P. falciparum—exists throughout the year in most of the South-western Region (except in the high-altitude areas of Asir Province) and in certain rural areas of the Western Region. No risk in Mecca or Medina cities. Chloroquine-resistant P. falciparum reported. Recommended prevention in risk areas: IV

CDC Country requirements: Vaccination required if traveling from an endemic zone. CDC recommendations: None.

WHO A yellow fever vaccination certificate is required from all travellers coming from countries, any parts of which are infected.

acquired immunodeficiency syndrome (AIDS)
amebiasis
anthrax
brucellosis
cholera
diphtheria
echinococcosis (Echinococcus granulosus)
filariasis (Wuchereria bancrofti)
giardiasis
hepatitis B
hepatitis delta
leishmaniasis, cutaneous
leishmaniasis, visceral
malaria
measles
meningococcal infections
mycetoma (Madura foot)
onchocerciasis
plague
poliomyelitis
rabies
schistosomiasis
syphilis, nonvenereal (endemic syphilis or bejel)
tuberculosis